Alfresa Holdings Corporation (TYO:2784)

Japan flag Japan · Delayed Price · Currency is JPY
2,391.00
+13.50 (0.57%)
Apr 28, 2026, 3:30 PM JST
11.57%
Market Cap 434.49B
Revenue (ttm) 3.06T
Net Income (ttm) 33.64B
Shares Out 181.72M
EPS (ttm) 184.82
PE Ratio 12.94
Forward PE 14.15
Dividend 68.00 (2.86%)
Ex-Dividend Date Mar 30, 2026
Volume 392,400
Average Volume 329,470
Open 2,393.50
Previous Close 2,377.50
Day's Range 2,370.00 - 2,408.00
52-Week Range 1,897.00 - 2,685.50
Beta -0.16
RSI 39.64
Earnings Date May 15, 2026

About Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract dis... [Read more]

Sector Healthcare
Founded 2003
Employees 12,452
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 2784
Full Company Profile

Financial Performance

In fiscal year 2025, Alfresa Holdings's revenue was 2.96 trillion, an increase of 3.59% compared to the previous year's 2.86 trillion. Earnings were 27.39 billion, a decrease of -7.34%.

Financial Statements

News

There is no news available yet.